How much does a box of Mobosetinib/Mobosetinib generic drug cost?
Mobocertinib/ Mobocertinib is a targeted therapy drug that targets specific mutations. It is mainly suitable for adult patients with locally advanced or metastatic non-small cell lung cancer who have been found to have EGFR exon 20 insertion mutations through tests approved by the U.S. Food and Drug Administration (FDA). The drug was developed to provide a new treatment option for patients who have failed conventional treatments, especially when disease progression has become apparent during or after platinum-based chemotherapy.
As the global demand for targeted therapy drugs increases, the original drug of moboxetinib has been launched in many countries and has achieved good clinical application results. At the same time, due to its remarkable therapeutic effects, pharmaceutical companies in many countries and regions have also begun to develop and produce generic drugs to meet the growing demand for this treatment option in the market.
Currently, several different versions of generic versions of moboxetinib have appeared on the market, among which the versions in Laos and Bangladesh are the most common. For example, the generic version of moboxetinib produced by Lucius Pharmaceuticals in Laos has a specification of 40 mg and 120 tablets, and the price is usually around 4,000 yuan. A similar product produced by Bangladesh's Ziska Pharmaceutical has a specification of 40 mg and 60 tablets, and the price is more than 3,000 yuan. It is important to note that these prices are affected by exchange rate fluctuations, market supply and demand, and other factors, and therefore may differ at the time of purchase.
In addition to price factors, patients should also consider the quality of the drug, the manufacturer and its local market reputation when choosing to use mobosetinib or its generic drugs. Although the ingredients of generic drugs are the same as the original drugs, the efficacy and safety of generic drugs may also be different due to factors such as production processes and raw material sources.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)